Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of Cobimetinib in Volunteers With and Without Liver Damage [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study of Cobimetinib in healthy volunteers with and without liver damage; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Cobimetinib (cobimetinib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Healthy Volunteer | Phase 1 | Status: COMPLETED | Results posted: 2016-02-19